Clinical Trial Update: Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated the safety and effectiveness of a combination of docetaxel, RAD001 (everolimus), and bevacizumab in men with advanced p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Everolimus (everolimus)

Snippet

Sponsor: University of Southern California | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED